COO vs WST
Cooper Companies (The) vs West Pharmaceutical Services — AI-powered side-by-side comparison
COO
Cooper Companies (The)
66
Buy
VS
WST
West Pharmaceutical Services
71
Buy
| Metric | COO | WST |
|---|
| AI Score |
66
|
71
|
| Price |
$74.25
|
$353.62
|
| P/E Ratio |
62.91×
|
44.99×
|
| ROE |
4.6%
|
15.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
64.4%
|
36.8%
|
| Debt / Equity |
0.30×
|
0.10×
|
| Dividend Yield |
0.0%
|
0.2%
|
| RSI (14) |
61.8
|
61.3
|
| Beta |
0.84
|
1.159
|
| Expected Upside |
+0.2%
|
—
|
AI Committee View
Current Innellis committee reasoning for COO versus WST.
WST leads by 5 points.
WST scores 71/100 (Buy) versus COO at 66/100 (Buy).
COO Committee View
75% agreement
4 analysts
The primary driver is 4 consecutive earnings beats -- consistent execution. The main limiting factor is news sentiment is negative (-0.18 across 11 articles, 14d). The committee is constructive but not yet at full conviction.
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- News sentiment is negative (-0.18 across 11 articles, 14d) — News
WST Committee View
100% agreement
4 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is 4 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical